Bausch Health Companies Inc (NYSE:BHC)
$ 6.88 -0.07 (-1.01%) Market Cap: 2.53 Bil Enterprise Value: 23.88 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 73/100

Bausch Health Companies Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Oct 02, 2019 / 02:05PM GMT
Release Date Price: $18.89 (-3.97%)
Louise Chen
Cantor Fitzgerald - Analyst

Okay, good morning. Welcome to the Cantor healthcare conference. I would like to introduce you to Joe Papa, the CEO of Bausch Health Company. And to begin, he has some opening remarks and slides and then we will get into Q&A.

Joe Papa
Bausch Health Companies Inc. - Chairman and CEO

So it certainly is a pleasure to be here with you, Louise, to have a chance to talk about Bausch Healthcare. We have labeled 2019 as our year that we were pivoting to offense. And clearly, we have had some great progress with our Bausch & Lomb business and the eye care business. We have had now 11 consecutive quarters of growth. Our Salix business in the last quarter was up 12%, so we are very pleased with that for Q2.

The one area that we've been lagging behind is our dermatology business. And what I want to do is share a few slides with you on dermatology. Specifically, some of what we think is great news on DUOBRII that we have actually posted to our website today, if anyone has interest in seeing those.

But

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot